tiprankstipranks
Trending News
More News >
LB Pharmaceuticals, Inc. (LBRX)
NASDAQ:LBRX
US Market
Advertisement

LB Pharmaceuticals, Inc. (LBRX) Income Statement

Compare
8 Followers

LB Pharmaceuticals, Inc. Income Statement

Last quarter (Q1 2024), LB Pharmaceuticals, Inc.'s total revenue was $0.00. In Q1, LB Pharmaceuticals, Inc.'s net income was $-16.15M. See LB Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 64.83M$ 11.38M$ 2.81M
Depreciation and Amortization
$ 91.00K$ 4.00K$ 2.00K
EBITDA
$ -63.01M$ -1.45M$ -12.19M
Operating Income
$ -64.83M$ -11.38M$ -2.81M
Other Income/Expenses
$ 1.73M$ 5.10M$ -11.54M
Pretax Income
$ -63.10M$ -6.27M$ -14.35M
Net Income
$ -63.10M$ -6.28M$ -14.35M
Per Share Metrics
Basic EPS
$ -17.83$ -1.77$ -4.05
Diluted EPS
$ -17.83$ -1.77$ -4.05
Weighted Average Shares Outstanding
3.54M 3.54M 3.54M
Weighted Average Shares Outstanding (Diluted)
3.54M 3.54M 3.54M
Currency in USD

LB Pharmaceuticals, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis